Validation of a Central Review Board of Staging prior to Surgery for Non-Small-Cell Lung Cancer – Impact on Prognosis: A Multicenter Study

Publisher： Karger

E-ISSN： 1423-0356|69|1|16-24

ISSN： 0025-7931

Source： Respiration, Vol.69, Iss.1, 2002-02, pp. : 16-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pathology of Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 72, Iss. 3, 2005-06 ,pp. : 313-330

Karger

Access to resources Recommend Favorite

Hycamtin in the Therapy of Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4165-4172

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 3-13

Karger

Access to resources Recommend Favorite

The impact of a serum based proteomic mass spectrometry test on treatment recommendations in advanced non-small-cell lung cancer

By Akerley Wallace L.   Nelson Richard E.   Cowie Robin H.   Spinella Dominic G.   Hornberger John  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 517-525

Informa Healthcare

Access to resources Recommend Favorite